Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 339, pseudogene (RN7SL339P)

Target
RN7SL339P
Molecular classification
Other (Pseudogene)
01

Overview

**RNA, 7SL, cytoplasmic 339, pseudogene (RN7SL339P)** is a member of a large family of human *7SL RNA pseudogenes*. These are genomic sequences that are highly similar to the functional 7SL RNA gene, but due to accumulated mutations, truncations, or other disruptions, do not code for functional RNA and are generally not transcribed into functional products[1][4]. 7SL RNA pseudogenes like RN7SL339P are evolutionary remnants and generally have no known biological function; they are the byproduct of retrotransposition events where 7SL RNA was copied back into the genome[4]. The canonical 7SL RNA (not the pseudogene) is an integral part of the **signal recognition particle (SRP)**, critical for cotranslational protein targeting; however, *RN7SL339P itself does not fulfill this biological role*[1][3][4]. **Key clarifications:** - RN7SL339P is a pseudogene, not a protein-coding gene or a functional non-coding RNA. - As a pseudogene, it is neither a receptor, enzyme, transporter, nor considered a drug target[1][4]. - Pseudogenes like RN7SL339P are not directly involved in human disease, targeted by drugs, or used as biomarkers. - The correct functional molecule is 7SL RNA (part of SRP), but RN7SL339P is a defunct copy[1][3][4]. - If you are searching for a therapeutic or biological target, RN7SL339P is not appropriate; the confusion may arise from similarity to the functional 7SL RNA gene[1][4].

Other names
RN7SL339PRNA, 7SL, cytoplasmic 339, pseudogene
02

Biological functions

Other (No known biological function; not expressed as a functional molecule)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 339, pseudogene (RN7SL339P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 339, pseudogene (RN7SL339P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call